Otsuka Holdings
4578.T
#632
Rank
HK$246.15 B
Marketcap
HK$456.96
Share price
-0.72%
Change (1 day)
60.75%
Change (1 year)
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.

Earnings for Otsuka Holdings (4578.T)

Earnings in 2024 (TTM): HK$7.65 Billion

According to Otsuka Holdings 's latest financial reports the company's current earnings are HK$14.47 Billion. In 2023 the company made an earning of HK$8.18 Billion a decrease over its 2022 earnings that were of HK$10.33 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Otsuka Holdings from 2010 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) HK$7.65 B-6.37%
2023 HK$8.18 B-20.82%
2022 HK$10.33 B-13.04%
2021 HK$11.88 B-19.69%
2020 HK$14.79 B13.78%
2019 HK$13.00 B52.13%
2018 HK$8.54 B11.32%
2017 HK$7.67 B-36.26%
2016 HK$12.04 B31.64%
2015 HK$9.15 B
2013 HK$19.04 B33.73%
2012 HK$14.24 B-4.78%
2011 HK$14.95 B46.23%
2010 HK$10.22 B